Geode Capital Management, LLC Tempest Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Tempest Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 354,276 shares of TPST stock, worth $272,792. This represents 0.0% of its overall portfolio holdings.
Number of Shares
354,276
Previous 220,067
60.99%
Holding current value
$272,792
Previous $308,000
3.57%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding TPST
# of Institutions
39Shares Held
6.35MCall Options Held
34.9KPut Options Held
148K-
Versant Venture Management, LLC San Francisco, CA3.51MShares$2.7 Million4.35% of portfolio
-
Black Rock Inc. New York, NY550KShares$423,6850.0% of portfolio
-
Jane Street Group, LLC New York, NY493KShares$379,6820.0% of portfolio
-
Ubs Group Ag196KShares$150,6700.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny190KShares$145,9190.0% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $8.02M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...